NITROMED
NitroMed is an emerging pharmaceutical company that discovers, develops and seeks to commercialize proprietary pharmaceuticals based on the therapeutic benefits of the naturally-occurring molecule nitric oxide. NitroMed is conducting a late-stage confirmatory trial of our lead nitric oxide-enhancing drug, BiDil, for the treatment of heart failure in African Americans.
NITROMED
Industry:
Biotechnology Medical Pharmaceutical
Founded:
1987-01-01
Address:
Bedford, Massachusetts, United States
Country:
United States
Website Url:
http://www.nitromed.com
Total Employee:
101+
Status:
Closed
Email Addresses:
[email protected]
Total Funding:
51.3 M USD
Technology used in webpage:
Google Apps For Business Network Solutions DNS FutureQuest
Current Advisors List
Current Employees Featured
Stock Details
Investors List
HealthCare Ventures
HealthCare Ventures investment in Series E - NitroMed
Morgan Stanley Expansion Capital
Morgan Stanley Expansion Capital investment in Series E - NitroMed
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation investment in Series E - NitroMed
Rho Ventures
Rho Ventures investment in Series E - NitroMed
Care Capital
Care Capital investment in Series E - NitroMed
Quintiles
Quintiles investment in Series E - NitroMed
Boston University Technology Development Fund
Boston University Technology Development Fund investment in Series E - NitroMed
Official Site Inspections
http://www.nitromed.com
- Host name: 69.5.14.68
- IP address: 69.5.14.68
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "NitroMed"
NitroMed - Crunchbase Company Profile & Funding
NitroMed is an emerging pharmaceutical company that discovers, develops and seeks to commercialize proprietary pharmaceuticals based on the therapeutic …See details»
Nitromed Company Profile 2024: Valuation, Investors
Information on acquisition, funding, investors, and executives for Nitromed. Use the PitchBook Platform to explore the full profile.See details»
NitroMed Inc - Company Profile and News - Bloomberg Markets
NitroMed, Inc. provides pharmaceutical products. The Company discovers, develops, and seeks to commercialize proprietary pharmaceuticals based on the therapeutic benefits of the...See details»
Nitromed - Morgan Stanley
Develops nitric oxide enhanced medicines. (NASDAQ:NTMD).See details»
NitroMed, Inc - Lexington, USA - bionity.com
Apr 24, 2009 · NitroMed, Inc. of Lexington, Massachusetts is a research-based emerging pharmaceutical company and the maker of BiDil, an orally administered medicine available in …See details»
NitroMed - Funding, Financials, Valuation & Investors - Crunchbase
NitroMed is an emerging pharmaceutical company with substantial expertise and intellectual property in nitric oxide-based drug development.See details»
NITROMED, INC. Company Profile | Lexington, MA | Competitors ...
Find company research, competitor information, contact details & financial data for NITROMED, INC. of Lexington, MA. Get the latest business insights from Dun & Bradstreet.See details»
NitroMed, Inc. - VentureRadar
Find out more about NitroMed, Inc. including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»
NitroMed - Products, Competitors, Financials, Employees, …
NitroMed is a pharmaceutical company and the maker of BiDil, an orally administered medicine available in the United States for the treatment of heart failure in self-identified black patients. …See details»
Nitromed Inc Company Profile | Oakville, ON, Canada
Find company research, competitor information, contact details & financial data for Nitromed Inc of Oakville, ON. Get the latest business insights from Dun & Bradstreet.See details»
NitroMed - Contacts, Employees, Board Members, Advisors
NitroMed is an emerging pharmaceutical company with substantial expertise and intellectual property in nitric oxide-based drug development.See details»
Organization | Nitromed
Nitromed Report issue. For profit Phase 4. Founded: Bedford MA United States (1987) Status: Defunct (2009) Organization Overview ...See details»
NitroMed, Inc. Information | CareersInPharmaceutical.com
NitroMed, Inc., is located at Lexington, MA and is a research-based emerging pharmaceutical company and the maker of BiDil, an orally administered medicine available in the United …See details»
NitroMed Announces Agreement to be Acquired by Deerfield …
Jan 30, 2009 · LEXINGTON, MA--(January 27, 2009) -NitroMed today announced that it entered into a merger agreement to be acquired by affiliates of Deerfield Management, a leading …See details»
Nitromed : NitroMed to Present at Cowen and Company Health …
Mar 7, 2007 · NitroMed, Inc. (NASDAQ: NTMD) today announced that Kenneth M. Bate, the Company's President and Chief Executive Officer, will present a corporate update at Cowen …See details»
NitroMed - CB Insights
Explore {NitroMed's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
NitroMed, Inc. and Archemix Corporation Announce Merger
Nov 19, 2008 · A live webcast over the Internet will be available at http://www.nitromed.com or at NitroMed-Archemix Merger Announcement Webcast and archived for two weeks. To listen …See details»
First 'black' drug nears approval | Nature
The drug, made by Massachusetts-based pharmaceutical company NitroMed, was abandoned after a trial in the 1980s produced unimpressive results.See details»
NitroMed - Tech Stack, Apps, Patents & Trademarks - Crunchbase
NitroMed is an emerging pharmaceutical company with substantial expertise and intellectual property in nitric oxide-based drug development.See details»
NitroMed, Inc. (NitroMed, Inc.) - 药物管线_专利_临床试验_投融营 …
了解NitroMed, Inc. (NitroMed, Inc.)公司的药物管线，治疗领域，技术平台，以及它的1项临床试, 4篇新闻和54篇文献，技术平台:小分子化药，药物:COX-2 inhibitors(NitroMed, Inc.)，NMI …See details»